Mitsubishi UFJ Trust & Banking Corp Boosts Stock Position in DENTSPLY SIRONA Inc. $XRAY

Mitsubishi UFJ Trust & Banking Corp grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1,836.7% during the 3rd quarter, Holdings Channel.com reports. The firm owned 105,938 shares of the medical instruments supplier’s stock after acquiring an additional 100,468 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in DENTSPLY SIRONA were worth $1,344,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of XRAY. Public Employees Retirement System of Ohio grew its position in DENTSPLY SIRONA by 1.4% during the second quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier’s stock valued at $983,000 after acquiring an additional 861 shares during the last quarter. True Wealth Design LLC boosted its stake in shares of DENTSPLY SIRONA by 49.7% in the 3rd quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock valued at $45,000 after purchasing an additional 1,181 shares in the last quarter. Sivia Capital Partners LLC grew its holdings in shares of DENTSPLY SIRONA by 5.3% during the 3rd quarter. Sivia Capital Partners LLC now owns 25,774 shares of the medical instruments supplier’s stock valued at $327,000 after purchasing an additional 1,293 shares during the last quarter. AlphaQuest LLC raised its position in DENTSPLY SIRONA by 2.5% in the 2nd quarter. AlphaQuest LLC now owns 52,817 shares of the medical instruments supplier’s stock worth $839,000 after purchasing an additional 1,294 shares during the period. Finally, Empowered Funds LLC lifted its stake in DENTSPLY SIRONA by 8.8% in the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock worth $244,000 after purchasing an additional 1,320 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

Insider Activity

In related news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 0.50% of the stock is owned by corporate insiders.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock opened at $12.47 on Friday. The company has a debt-to-equity ratio of 1.36, a quick ratio of 0.99 and a current ratio of 1.47. DENTSPLY SIRONA Inc. has a fifty-two week low of $9.85 and a fifty-two week high of $20.27. The firm has a market cap of $2.49 billion, a P/E ratio of -2.82, a P/E/G ratio of 0.96 and a beta of 1.00. The business’s 50 day moving average price is $11.75 and its 200-day moving average price is $12.76.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The business had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.The business’s revenue was down 4.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. On average, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 5.1%. DENTSPLY SIRONA’s payout ratio is presently -14.48%.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, January 21st. Evercore ISI reduced their price target on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research report on Wednesday, October 8th. Stifel Nicolaus set a $13.00 price target on DENTSPLY SIRONA in a research note on Thursday, November 6th. JPMorgan Chase & Co. dropped their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Friday, November 7th. Finally, Zacks Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Two research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average price target of $14.83.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.